Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

FDA clears Vertex’s new treatment for cystic fibrosis

By , Globe Staff

The therapy will cost $259,000 per patient per year, and is expected to generate billions annually for the Boston-based company.

Biogen plans $1 billion plant in Switzerland

By , Globe Staff

The manufacturing investment would triple the Cambridge company’s capacity to produce drugs known as biologics.

ConforMIS shares climb after $135 million IPO

By , Globe Staff

Shares of ConforMIS Inc. rose 28 percent in their stock market debut Wednesday after the Bedford-based medical technology company raised $135 million in an initial public offering.

Destination for reluctant but hopeful travelers

By , Globe Staff

Mayo Clinic has turned Rochester, Minn., into a thriving destination for tourists from every state and 140 countries.